You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

CLINICAL TRIALS PROFILE FOR SUMAVEL DOSEPRO

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for SUMAVEL DOSEPRO

Subscribe to access the full database, or Subscribe
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT01016834 ↗	Evaluation of Treatment Satisfaction and Preference for Sumavel DosePro in the Treatment of Migraine	Completed	Synteract, Inc.	Phase 4	2009-11-01	The purpose of the study is to evaluate the treatment satisfaction of subjects using Sumavel DosePro to treat their moderate to severe migraines.
NCT01016834 ↗	Evaluation of Treatment Satisfaction and Preference for Sumavel DosePro in the Treatment of Migraine	Completed	Zogenix, Inc.	Phase 4	2009-11-01	The purpose of the study is to evaluate the treatment satisfaction of subjects using Sumavel DosePro to treat their moderate to severe migraines.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for SUMAVEL DOSEPRO

Condition Name

Chart
Table

Condition Name for SUMAVEL DOSEPRO
Intervention	Trials
Migraine	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for SUMAVEL DOSEPRO
Intervention	Trials
Migraine Disorders	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for SUMAVEL DOSEPRO

Trials by Country

Map
Table

Trials by Country for SUMAVEL DOSEPRO
Location	Trials
United States	16
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for SUMAVEL DOSEPRO
Location	Trials
Washington	1
Tennessee	1
Pennsylvania	1
Ohio	1
North Carolina	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for SUMAVEL DOSEPRO

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for SUMAVEL DOSEPRO
Clinical Trial Phase	Trials
Phase 4	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for SUMAVEL DOSEPRO
Clinical Trial Phase	Trials
Completed	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for SUMAVEL DOSEPRO

Sponsor Name

Chart
Table

Sponsor Name for SUMAVEL DOSEPRO
Sponsor	Trials
Synteract, Inc.	1
Zogenix, Inc.	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for SUMAVEL DOSEPRO
Sponsor	Trials
Industry	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.